Home World News Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent Hormone-Sensitive... World News Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer By Ogkologos - November 24, 2025 493 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the LUNAR study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Characterisation of KRAS, Including KRAS G12C, Mutations in Gastrointestinal and Metastatic... July 2, 2021 Sen. Amy Klobuchar Announces Breast Cancer Diagnosis, Urges Women Not to... September 10, 2021 A urine test for bladder cancer: What’s the latest? April 16, 2022 Scientists Link a Single Type of Bacteria to Colorectal Cancer April 19, 2024 Load more HOT NEWS Significant Benefits of Nivolumab Plus Cabozantinib Over Sunitinib in Previously Untreated... Navigating the Challenges of Gynecologic Cancer Survivorship: An Expert Perspective E-cigarettes: what we know and what we don’t Pan-FGFR Tyrosine Kinase Inhibitor Treatment Is Less Effective in Patients with...
